Research.Patient.info

Eosinophilic granulomatosis with polyangiitis (EGPA) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingTherapeutic confirmatory (Phase III)
E-merge - Evaluation of MEpolizumab-based regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Eosinophilic Granulomatosis With Polyangiitis. Prospective, randomized, controlled, double-blind study
This study is testing a new way to treat EGPA, a rare condition causing inflammation. It compares a new drug called mepolizumab to standard treatments to see if it can help patients reduce their steroid dose and avoid flare-ups.
France